10 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 9 Not applicable, 4 Phase 1, 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 8, Recruiting 1 |
| Phase 1 | 4 | Not yet recruiting 2, Completed 1, Recruiting 1 |
| Early Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Basic Science: new trials by email Literature Review of Basic Science trials Research Report on Basic Science
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Bioequivalence of RAY1225 Injection in Healthy Participants RAY1225 - Basic Science | Phase 1 | Not yet recruiting | Guangdong Raynovent Biotech Co., Ltd | 68 | 2026-09-21 | 2026-09-18 |
| A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants 14C-RAY1225 - Basic Science | Phase 1 | Not yet recruiting | Guangdong Raynovent Biotech Co., Ltd | 8 | 2026-03-15 | 2026-03-10 |
| Acute Effects of Maximal Exercise on Balance and Cognitive Domains in Young Men maximal exercise - Basic Science | Not applicable | Completed | University School of Physical Education, Krakow, Poland | 30 | 2024-11-20 | 2026-03-05 |
| A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants Placebo, Olpasiran, Moxifloxacin - Basic Science | Phase 1 | Completed | Amgen | 32 | 2024-09-12 | 2026-10-23 |
| Comprehensive Multi-omics Characterization and Implications of Non-Pharmaceutical Dental Hygiene Product in a Randomized Controlled Large Population Study. Oral Lozenges (Tradename pHossident), Water additive (Tradename Protektin) - Basic Science, Intervention Studies | Not applicable | Completed | Delta Dental of Minnesota Foundation | 595 | 2024-04-30 | 2026-03-05 |
| LSD Occupancy of the Serotonin 2A Receptor in the Human Brain Lysergic Acid Diethylamide Tartrate - Basic Science | Early Phase 1 | Active not recruiting | Copenhagen University Hospital, Rigshospitalet | 40 | 2023-11-08 | 2026-07-02 |
| Frontal and Parietal Contributions to Proprioception and Motor Skill Learning Theta burst transcranial magnetic stimulation, Sham theta burst transcranial magnetic stimulation - Basic Science | Not applicable | Completed | Indiana University | 118 | 2023-06-09 | 2025-12-05 |
| Clinical Effectiveness of the Calcium Chloride (CaCl2) Surface- Treated Orthodontic Mini Implant (OMI) calcium chloride surface treatment in mini implant, Acid Etched - Basic Science, Orthodontic Appliance Complication | Not applicable | Completed | Universiti Teknologi Mara | 48 | 2023-01-09 | 2024-09-23 |
| Factors Affecting Sensory and Motor Learning Explanatory diagram, Direct vision, Movement feedback, target hand - Basic Science | Not applicable | Completed | Indiana University | 389 | 2022-04-29 | 2026-08-31 |
| Neural Basis of Sensory and Motor Learning: Functional Connections Perceptual learning - Basic Science | Not applicable | Completed | Indiana University | 76 | 2022-04-13 | 2026-01-28 |
| Neural Basis of Sensory Learning: Brain Regions Theta burst transcranial magnetic stimulation - Basic Science | Not applicable | Recruiting | Indiana University | 300 | 2021-10-26 | 2026-05-04 |
| Influence of Oxytocin on Approach-avoidance Tendencies to Social and Non-social Stimuli Oxytocin, Placebo - Basic Science | Not applicable | Completed | KU Leuven | 64 | 2018-12-15 | 2020-06-23 |
| Phosphate Metabolites in Brain of Humans Aged 50+ Peptamen® 1.5 Vanilla, Boost Plus® Vanilla - Basic Science | Not applicable | Completed | Société des Produits Nestlé (SPN) | 25 | 2018-05-14 | 2018-12-05 |
| The Neurobiological Effect of 5-HT2AR Modulation Psilocybine, Ketanserin - Basic Science | Phase 1 | Recruiting | Gitte Moos Knudsen | 200 | 2017-03-03 | 2024-12-16 |
| The Effects of Buprenorphine on Responses to Verbal Tasks Buprenorphine 0.2 MG Sublingual Tablet, Placebo, Buprenorphine 0.4 MG Sublingual Tablet - Basic Science | Early Phase 1 | Completed | University of Chicago | 48 | 2013-09-01 | 2019-08-01 |
Malocclusion (1) · Social Behavior (1)
Behavior (1) · Stomatognathic Diseases (1) · Tooth Diseases (1)
Administration, Sublingual (1) · Buprenorphine (1) · Denture, Partial, Fixed, Resin-Bonded (1) · Ketanserin (1) · Lysergic Acid Diethylamide (1) · Moxifloxacin (1) · Oxytocin (1) · Psilocybin (1) · olpasiran (1)
Indiana University (4) · Guangdong Raynovent Biotech Co., Ltd (2) · Amgen (1) · Copenhagen University Hospital, Rigshospitalet (1) · Delta Dental of Minnesota Foundation (1) · Gitte Moos Knudsen (1) · KU Leuven (1) · Société des Produits Nestlé (SPN) (1) · Universiti Teknologi Mara (1) · University School of Physical Education, Krakow, Poland (1) · University of Chicago (1)
United States (6) · Denmark (2) · Belgium (1) · China (1) · Malaysia (1) · Poland (1) · Switzerland (1) · United Kingdom (1)
Bruce Templeton, DMD (1) · David Koceja, PhD (1) · Gitte M Knudsen, DMsc, MD (1) · Gitte M Knudsen, Professor (1) · Hannah Block (1) · Harriet de Wit, Ph.D. (1) · Jerome Jaffe, M.D. (1) · Kaat Alaerts, PhD (1) · William P Hetrick, PhD (1)
PMID 34880300, PMID 42212900, PMID 42457666
R01NS112367 (4)